Barclays’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Other funds holding IHI
Barclays's IHI Position: Q1 2026 in Review
Barclays increased its iShares US Medical Devices ETF (IHI) stake by 8,749% in Q1 2026, buying an estimated $5.92M and bringing the position to 101,945 shares worth $5.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1764.
Barclays first reported a position in IHI in Q2 2013 and has held it in 34 quarters since. The position peaked at $61.9M in Q2 2021. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.
- Barclays held 101,945 shares of iShares US Medical Devices ETF worth $5.44M as of Q1 2026.
- Barclays bought 100,793 iShares US Medical Devices ETF shares in Q1 2026, an estimated $5.92M.
- iShares US Medical Devices ETF made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1764 holding.
- Barclays first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 34 quarters since.
- Barclays's iShares US Medical Devices ETF position peaked at $61.9M in Q2 2021.
- 504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.